Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

Specimen Handling 76 Bevacizumab 66 Cisplatin 64 Drug Therapy 63 Carboplatin 63 Magnetic Resonance Spectroscopy 59 Radiotherapy 57 pembrolizumab 54 Gemcitabine 54 Cyclophosphamide 54 Capecitabine 51 Oxaliplatin 50 toripalimab 44 tislelizumab 40 Paclitaxel 40 Standard of Care 39 fludarabine 36 Fluorouracil 35 Injections 34 Biopsy 34 venetoclax 33 Blood Specimen Collection 31 Immune Checkpoint Inhibitors 30 anlotinib 29 Surgical Procedures, Operative 28 Nivolumab 28 Irinotecan 27 Docetaxel 27 Dexamethasone 27 Leucovorin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × tegafur-gimeracil-oteracil × 1 year × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡